Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction

Journal of the American College of Cardiology

Volumn 61, Issue 1, 2013, Pages 35-40

  Rassi, Andrew N ^a   Cavender, Matthew A ^a   Fonarow, Gregg C ^b   Cannon, Christopher P ^c   Hernandez, Adrian F ^d   Peterson, Eric D ^d   Peacock, W Frank ^e   Laskey, Warren K ^f   Rosas, Sylvia E ^g   Zhao, Xin ^h   Schwamm, Lee H ⁱ   Bhatt, Deepak L ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h DUKE CLINICAL RESEARCH INSTITUTE   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

acute myocardial infarction; aldosterone antagonist; heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST;

ACUTE HEART INFARCTION; AGED; ARTICLE; DIABETES MELLITUS; DRUG USE; DRUG UTILIZATION; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HOSPITAL; HOSPITAL DISCHARGE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; TOBACCO DEPENDENCE; TREND STUDY;

AGED; DIABETES MELLITUS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; GUIDELINE ADHERENCE; HEART FAILURE; HOSPITAL BED CAPACITY; HUMANS; KIDNEY DISEASES; MALE; MINERALOCORTICOID RECEPTOR ANTAGONISTS; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PATIENT DISCHARGE; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; SMOKING; STROKE VOLUME; UNITED STATES;

EID: 84872022727     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.08.1019     Document Type: Article

References (15)

1. B. Pitt, F. Zannad, W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
2. S.A. Hunt, W.T. Abraham, M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 2009 e1 e90
3. J. Lindenfeld, N.M. Albert, J.P. Boehmer HFSA 2010 comprehensive heart failure practice guideline J Card Fail 16 2010 e1 e194
4. F. Zannad, J.J. McMurray, H. Krum Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
5. B. Pitt, W. Remme, F. Zannad Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
6. P. Rossignol, J. Menard, R. Fay, F. Gustafsson, B. Pitt, F. Zannad Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects: insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy J Am Coll Cardiol 58 2011 1958 1966
7. E.M. Antman, D.T. Anbe, P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) J Am Coll Cardiol 44 2004 e1 e212
8. E.M. Antman, M. Hand, P.W. Armstrong 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee J Am Coll Cardiol 51 2008 210 247
9. J.L. Anderson, C.D. Adams, E.M. Antman ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J Am Coll Cardiol 50 2007 e1 e157
10. N.M. Albert, C.W. Yancy, L. Liang Use of aldosterone antagonists in heart failure JAMA 302 2009 1658 1665
11. M.J. Krantz, A.V. Ambardekar, L. Kaltenbach, A.F. Hernandez, P.A. Heidenreich, G.C. Fonarow Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure) Am J Cardiol 107 2011 1818 1823
12. J. Lachaine, C. Beauchemin, E. Ramos Use, tolerability and compliance of spironolactone in the treatment of heart failure BMC Clin Pharmacol 11 2011 4
13. B. Pitt, G. Bakris, L.M. Ruilope, L. DiCarlo, R. Mukherjee Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Circulation 118 2008 1643 1650
14. R. Ramaraj Eplerenone in patients with acute myocardial infarction complicated by heart failure Hypertension 52 2008 e147 author reply e48
15. W.S. Weintraub, Z. Zhang, E.M. Mahoney Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure Circulation 111 2005 1106 1113